SuperworthTango Therapeutics shares outstanding TNGX
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 149.9M
- On a year earlier
- +35.6%
- more shares
Tango Therapeutics had 149.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 35.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 132.2M | +20% |
| FY2024 | 109.9M | +5% |
| FY2023 | 104.4M | +19% |
| FY2022 | 87.7M | −0% |
| FY2021 | 88M | +119% |
| FY2020 | 40.1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 149.9M | +36% | |
| Q1 FY26 | 143.6M | +30% | |
| Q4 FY25 | 132.2M | +20% | |
| Q3 FY25 | 117.8M | +9% | |
| Q2 FY25 | 110.5M | +2% | |
| Q1 FY25 | 110.3M | +2% | |
| Q4 FY24 | 109.9M | +5% | |
| Q3 FY24 | 108.5M | +12% | |
| Q2 FY24 | 108.3M | +23% | |
| Q1 FY24 | 108.2M | +23% | |
| Q4 FY23 | 104.4M | +19% | |
| Q3 FY23 | 97M | +10% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Tango Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.